X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Clinical Epigenetics

期刊標題檢索 CLIN EPIGENETIC 最新評論: It's been about five months since then (2024-03-17)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Clinical Epigenetics]您好,您是該頁面的第 6535 位訪客。

期刊簡介
期刊名稱Clinical Epigenetics Clinical Epigenetics
LetPub Score
7.0
50 ratings
Rate

Reputation
8.2

Influence
6.1

Speed
7.0

期刊簡稱CLIN EPIGENETICS
ISSN1868-7075
E-ISSN1868-7083
h-indexN.A.
CiteScore
CiteScoreSJRSNIPCiteScore Rank
8.901.7271.019
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Genetics (clinical)
Q113 / 99
Category: Medicine
Subcategory: Developmental Biology
Q114 / 82
Category: Medicine
Subcategory: Genetics
Q160 / 347
Category: Medicine
Subcategory: Molecular Biology
Q196 / 410

自引率 (2023-2024)4.20%自引率趨勢
掲載範囲
Clinical Epigenetics, the official journal of the Clinical Epigenetics Society, is an open access, peer-reviewed journal that encompasses all aspects of epigenetic principles and mechanisms in relation to human disease, diagnosis and therapy. Clinical trials and research in disease model organisms are particularly welcome.
官方網站https://www.springer.com/journal/13148
在線稿件提交https://www.editorialmanager.com/CLEP
開放訪問Yes
出版商BioMed Central
主題領域Biochemistry, Genetics and Molecular Biology
出版國/地區Germany
發行頻率
創刊年2010
每年文章數192每年文章數趨勢
黃金OA百分比99.33%
OA Related Info
APC: Yes( GBP2490; USD3390; EUR2890; )
APC waiver:Check Notes
Other charges: No
Keywords: genetic processes、epigenetic therapy
Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
GENETICS & HEREDITYSCIEQ129/191
ONCOLOGYSCIEQ170/322
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1868-7075%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: 12 Weeks
競爭力 *來自作者的數據:
參考鏈接
相關期刊 【Clinical Epigenetics】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    EvoDevoH-index: 31

    CiteScore: 7.50
    Journal of Developmental BiologyH-index: 0

    CiteScore: 4.10
    OrganogenesisH-index: 41

    CiteScore: 4.10
    Results and Problems in Cell DifferentiationH-index: 0

    CiteScore: 1.90
    Stem Cell InvestigationH-index: 0

    CiteScore: 5.80
    Cells and DevelopmentH-index: 0

    CiteScore: 3.70
    學科內最受檢索的期刊 頁面查看次數
    Organogenesis13272
    EvoDevo10247
    Cells and Development2830
    Journal of Developmental Biology2653
    Stem Cell Investigation2428
    Results and Problems in Cell Differentiation1565
  •  

    Clinical Epigenetics Clinical Epigenetics
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    4    5    下一頁    末頁  (頁
/5)
  [Clinical Epigenetics] 的評論撰寫評論
作者: Phoebe


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-17 22:03:26 評論於
It's been about five months since then
(0) 讚! | Phoebe

作者: Phoebe


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-17 20:45:00 評論於
Review speed: 3.0 | Submission hit rate: 50.0
Emphasized research areas: DNA methylation; tumors; epigenetic
Sharing experience: Submitted in October 2023, revised and resubmitted on January 3, 2024, accepted on March 18, 2024, did not delay my graduation, goodbye academia
(0) 讚! | Phoebe

作者: 中原和雅


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-13 09:10:56 評論於
Submitted on December 6th, still waiting for external review. Should I dare to urge for submission? Really anxious
(0) 讚! | 中原和雅

作者: 无冬德海


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-09 15:08:20 評論於
Getting ready to submit my manuscript, I have read the comments from everyone. I am anxious to submit my article. I wonder if it is not suitable for this journal
(0) 讚! | 无冬德海

作者: 文娟Sama


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-27 21:51:11 評論於
How often do you update your status? Thank you
(0) 讚! | 文娟Sama

作者: 文娟Sama


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-25 22:53:57 評論於
Research focus: Epigenetics Experience Sharing: Is the Editor assigned externally Editor appointed, and when clicked, it shows "Submission under peer review". Is this status indicating that an editor is being sought? Will the status be updated once an editor is found?
(0) 讚! | 文娟Sama

作者: 文娟Sama


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-29 21:28:00 評論於
Do you need the original WB data from me?
(0) 讚! | 文娟Sama

作者: 华清含蕊


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-24 18:41:41 評論於
Hello editor assigned, how long has it been since the changes occurred? It has been 10 days for me and there have been no changes
(0) 讚! | 华清含蕊

作者: 达纳马库斯


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-13 09:25:29 評論於
My article has been accepted for publication,  keep it up!
(0) 讚! | 达纳马库斯

作者: Phoebe


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-05 21:23:38 評論於
Brother, how are you doing? I am also an appointed editor, and when you click into it, it is peer review. It has been a month
(0) 讚! | Phoebe

作者: 达纳马库斯


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-01 21:49:16 評論於
Review speed: 2.0 | Submission success rate: 50.0 Emphasized research direction: DNA methylation; Tumor experience sharing: Submitted on 230808, 1 Reviewer report received on 230929, Editor appointed on 231003. Is this a setback?
(0) 讚! | 达纳马库斯

作者: 苍风孟州


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-05-17 12:32:20 評論於
Exciting comments, you need to log in to view
(0) 讚! | 苍风孟州

作者: Ralap Edison


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-05-10 16:35:37 評論於
How long does it take to receive proofs after accepting? I have been stuck on verifying my email address
(0) 讚! | Ralap Edison

作者: 明冠冬晴


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-04-22 09:52:25 評論於
Does everyone need a summary?
(0) 讚! | 明冠冬晴

作者: 极乐醉安


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-04-13 12:24:28 評論於
Could you please explain what it means when the editor is appointed on the homepage, but when we click in it says "under peer review"? Has it been sent for review?
(0) 讚! | 极乐醉安

作者: Gabriel Lizzie


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-03-30 19:50:37 評論於
01-12 revised, 03-12 second revision, 03-22 accepted, 03-29 online
(0) 讚! | Gabriel Lizzie

作者: Sigrid Hamlet


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-01-11 15:24:33 評論於
Received on January 10, 2023, farewell to the rivers and lakes!
(0) 讚! | Sigrid Hamlet

作者: Gabriel Lizzie


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-01-10 15:02:47 評論於
It has been over 4 months now. Have you heard anything?
(0) 讚! | Gabriel Lizzie

作者: Sigrid Hamlet


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-01-09 15:42:42 評論於
Made two minor corrections, applied for a 45-day extension due to additional experiments. The current status after resubmission is "1 Reviewer report received"
(0) 讚! | Sigrid Hamlet

作者: 南风明艳


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-12-17 17:52:46 評論於
Have you received it?
(0) 讚! | 南风明艳

作者: 南风明艳


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-12-17 10:10:22 評論於
How are you doing?
(0) 讚! | 南风明艳

作者: 西风英飙


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-12-08 20:57:53 評論於
The submission system is extremely slow and continues to be unstable. It's a laid-back journal
(0) 讚! | 西风英飙

作者: Gabriel Lizzie


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-11-30 21:53:39 評論於
Submitted on 08-24-2022, reviewers invited on 08-31, reviewers agreed on 09-05, and reviews received on 09-14. It's been three months now and still no news
(0) 讚! | Gabriel Lizzie

作者: Gabriel Lizzie


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-11-30 20:25:54 評論於
Is there a result yet?
(0) 讚! | Gabriel Lizzie

作者: Sigrid Hamlet


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-11-14 19:46:47 評論於
11.14 Reviewer reports received / Ready for editor’s decision, the speed seems a bit fast, is it a bad sign for the ending?
(0) 讚! | Sigrid Hamlet

首頁    上一頁    1    2    3    4    5    下一頁    末頁  (頁
/5)

開始撰寫 [Clinical Epigenetics] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*